Description

3-(2-Methoxyphenyl)-4-Oxo-2-(Trifluoromethyl)-4H-Chromen-7-Yl Cyclopropanecarboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its complex chromene-based structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs) targeting a range of therapeutic areas. It is primarily sought after by pharmaceutical R&D laboratories, agrochemical innovators, and fine chemical manufacturers for its role as a key building block in complex organic synthesis.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug candidates, particularly those with chromene or benzopyran scaffolds.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for potential therapeutic agents.
• Agrochemical Synthesis: Serves as a building block for developing novel crop protection agents and pesticides.
• Fine Chemical Production: Employed in the custom synthesis of complex, high-value specialty chemicals for various industrial applications.
• Academic & Institutional R&D: Utilized in university and research institute laboratories for exploratory organic synthesis and methodological studies.

Basic Information

Product Name	3-(2-Methoxyphenyl)-4-Oxo-2-(Trifluoromethyl)-4H-Chromen-7-Yl Cyclopropanecarboxylate
CAS No.	637748-34-6
Molecular Formula	C21H15F3O5
Molecular Weight	404.34 g/mol
Synonyms	7-(Cyclopropanecarbonyloxy)-3-(2-methoxyphenyl)-2-(trifluoromethyl)-4H-chromen-4-one; 3-(2-Methoxyphenyl)-2-(trifluoromethyl)-4-oxo-4H-chromen-7-yl cyclopropanecarboxylate; Cyclopropanecarboxylic acid, 3-(2-methoxyphenyl)-2-(trifluoromethyl)-4-oxo-4H-1-benzopyran-7-yl ester; 7-O-Cyclopropanecarbonyl-3-(2-methoxyphenyl)-2-trifluoromethylchromone
EINECS	Contact for details

Quality Control

Our 3-(2-Methoxyphenyl)-4-Oxo-2-(Trifluoromethyl)-4H-Chromen-7-Yl Cyclopropanecarboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong bases and oxidizing agents. For long-term storage, consider inert atmosphere conditions to ensure product integrity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.